GEHC

SEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 3

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,990

Underlying: Common stock, par value $0.01 per share · 1,990 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F4 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024.

F4 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024.

F4 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024.

SEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 2

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,397

Underlying: Common stock, par value $0.01 per share · 17,397 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F3 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.

F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.

F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.

SEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 1

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,878

Underlying: Common stock, par value $0.01 per share · 11,878 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F2 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F2 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F2 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 16

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,549

Underlying: Common stock, par value $0.01 per share · 2,549 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F9 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F9 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 15

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common stock, par value $0.01 per share · 2,599 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 14

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,261

Underlying: Common stock, par value $0.01 per share · 1,261 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 12

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,416

Underlying: Common stock, par value $0.01 per share · 8,416 shares

Expires 2030-03-02

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 11

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,229

Underlying: Common stock, par value $0.01 per share · 3,229 shares

Expires 2029-04-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 10

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,835

Underlying: Common stock, par value $0.01 per share · 6,835 shares

Expires 2029-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 9

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,638

Underlying: Common stock, par value $0.01 per share · 6,638 shares

Expires 2028-12-21

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 8

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,434

Underlying: Common stock, par value $0.01 per share · 2,434 shares

Expires 2027-11-17

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 7

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,592

Underlying: Common stock, par value $0.01 per share · 4,592 shares

Expires 2026-09-30

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 6

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,672

Underlying: Common stock, par value $0.01 per share · 3,672 shares

Expires 2025-09-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 5

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,672

Underlying: Common stock, par value $0.01 per share · 3,672 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 4

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,672

Underlying: Common stock, par value $0.01 per share · 3,672 shares

Expires 2023-09-13

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001119 · doc4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,417

Underlying: Common stock, par value $0.01 per share · 4,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · balance_after: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001119 · doc4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,041

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · balance_after: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001112 · doc4.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001103 · doc4.xml · derivative · entry 4

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 588

Underlying: Common stock, par value $0.01 per share · 588 shares

Expires not disclosed

F4 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F5 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F5 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 3

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,959

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · shares: Represents performance shares that will vest, subject to continued service conditions and accelerated vesting in certain circumstances, based upon a weighted-average of the highest average closing price of GE's common stock and GE HealthCare's common stock for any 30 consecutive trading days during the performance period from January 3, 2023 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of GE's common stock over the period of 30 consecutive trading days up to and including August 18, 2020 (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price.

F3 · shares: No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 2

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trusts

Disclosed balance after: 524

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By holding company

Disclosed balance after: 70,403

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001122 · doc4.xml · derivative · entry 1

LESJAK CATHERINE A · CIK 0001256992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,192

Underlying: Common stock, par value $0.01 per share · 3,192 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F2 · price: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001115 · doc4.xml · derivative · entry 1

Mihaljevic Tomislav · CIK 0001917584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 559

Underlying: Common stock, par value $0.01 per share · 559 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F2 · price: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001113 · doc4.xml · nonDerivative · entry 1

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001111 · doc4.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Indirect · By share incentive plan trust

Disclosed balance after: 59

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001105 · doc4.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001100 · doc4.xml · derivative · entry 13

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28

Underlying: Common stock, par value $0.01 per share · 28 shares

Expires not disclosed

F4 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F5 · derivative.exercise_date: Award of phantom stock with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Payable after termination of service. This transaction is being reported notwithstanding the exemption provided by Rule 16a-9.

F5 · derivative.expiration_date: Award of phantom stock with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Payable after termination of service. This transaction is being reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001100 · doc4.xml · nonDerivative · entry 3

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k)

Disclosed balance after: 143

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001100 · doc4.xml · nonDerivative · entry 2

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By family member

Disclosed balance after: 12

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001100 · doc4.xml · nonDerivative · entry 1

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 439

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0000899243-23-001106 · doc4.xml · nonDerivative · entry 1

GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,331,302

F1 · security: On December 16, 2022, General Electric Company, a Delaware corporation ("GE"), reported that it owned 100 shares, par value $0.01 per share, of GE Healthcare Holding LLC, which at the time constituted all of the issued and outstanding limited liability company units of GE Healthcare Holding LLC. On December 29, 2022, GE Healthcare Holding LLC converted from a limited liability company to a corporation and changed its name to GE HealthCare Technologies Inc. In connection therewith, the outstanding shares of GE HealthCare Technologies Inc. changed to 453,926,139 shares of common stock, par value $0.01 per share.

F2 · kind: The record date for the distribution by GE of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. to the holders of GE common shares was December 16, 2022. The distribution of shares of common stock of GE HealthCare Technologies Inc. occurred after the close of business on January 3, 2023.

F2 · price: The record date for the distribution by GE of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. to the holders of GE common shares was December 16, 2022. The distribution of shares of common stock of GE HealthCare Technologies Inc. occurred after the close of business on January 3, 2023.